Sexually transmitted diseases and HIV infections declined 2% in Minnesota last year, but health officials are uncertain whether that is because of underreporting amid the COVID-19 pandemic, reduced sexual activity or other factors.
STDs involving chlamydia, gonorrhea and syphilis declined 1% from 33,725 in 2019 to 33,252 in 2020, while new HIV infections dropped 18% from 276 in 2019 to 226 in 2020 — despite the discovery of distinct HIV outbreaks in Minneapolis and Duluth over the past three years.
People at risk for STDs and HIV need to seek regular testing and complete treatments for any diagnosed infections — especially considering that antiviral medications can drive HIV to undetectable levels, said Dr. Ruth Lynfield, state epidemiologist. "This is so essential, because people living with HIV who are taking their medications and have an undetectable viral load do not pass HIV through sex."
Minnesota's STD numbers had routinely reached record highs, largely through increases in diagnosed cases of chlamydia — an infection that often results in mild or no symptoms but can lead to infertility in women and other complications.
Chlamydia cases dropped 11% last year to 21,942 — an oddity because the annual number had risen every year since 2009. But then gonorrhea cases increased by 27% in the same year, surpassing 10,000 for the first time in Minnesota.
That kind of divergence in the numbers is "head-scratching," said Jill Farris, director of adolescent sexual health training and education for the University of Minnesota Medical School's Healthy Youth Development Prevention Research Center.
Antibiotic-resistant strains might have fueled growth of gonorrhea, she said. People during the pandemic also might have had an easier time taking the oral antibiotics to treat chlamydia, but not the injections to treat gonorrhea and prevent its spread.
Farris said she suspects fewer people during the pandemic sought testing for chlamydia because it can be asymptomatic, and that infections might have increased.